Clinical Trial

Comparison of Nutritional Information With Iron-succinate Supplementation in Healthy Women

Study acronym: Fe-Health
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated October 18, 2024 (before its estimated December 2024 completion). Its status may not reflect the trial's current state.
Summary
The primary aim of the current study is to evaluate the effects of dietary nutritional advice with regards to iron rich food sources or a daily oral supplement of 100 mg ferrous iron succinate in 80 menstruating, healthy women aged 20-40 years for 8 weeks. The study will use a randomized controlled non-blinded design, and 80 healthy women aged 20-40 years whom regularly exercise will be included. Data collection will be made through online, standardized forms using the digital platform REDCap 13.1.28 (Vanderbilt University, Nashville, TN, USA). Study personnel will register laboratory and body weight results through the same system. Participants will be randomized 1:1 to either follow written dietary recommendations to increase their dietary iron intake, or to use a daily oral supplement of 100 mg of iron succinate. Study parameters are blood tests (fasting blood samples will be collected by a licensed laboratory: serum iron, serum transferrin, serum transferrin saturation, serum ferritin, and serum soluble transferrin receptor, blood status (hemoglobin, MCV, MCH, MCHC, thrombocytes, leukocytes), and plasma high-sensitivity C-reactive protein (hsCRP) and Body height and weight as well as questionnaires.
Trial Details
NCT Number NCT06648018
Lead Sponsor University Hospital, Linkoeping
Collaborators: Primary Health Care Center, Region Östergötland, Linkoeping University
Conditions Well Being
Enrollment 80 participants
Start Date 2024-10-15
Primary Completion 2024-12 (estimated)
Study Completion 2025-01 (estimated)
Updated on ClinicalTrials.gov 2024-10-18